PSG2 impairs human trophoblast function in preeclampsia by activating TGF-β/Smad3 to suppress EMT and MMP2/9 expression
Biology of Reproduction · 2026
DOI: 10.1093/biolre/ioag168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of Reproduction, 2026. Verfasst von Yanping Qin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Trophoblasts, Smad3 Protein, Epithelial-Mesenchymal Transition. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
Preeclampsia is a severe pregnancy-specific disorder featured by insufficient extravillous trophoblast invasion and impaired spiral artery remodeling. Pregnancy-specific beta-1-glycoprotein 2, a placenta-derived protein, is significantly elevated in the serum of preeclampsia patients, yet its exact role and underlying mechanism in trophoblast function remain largely unknown. We demonstrated that pregnancy-specific beta-1-glycoprotein 2 was remarkably upregulated in preeclampsia placentas and its expression correlated positively with blood pressure and proteinuria, and negatively with gestational age and birth weight. In HTR-8/SVneo trophoblast cells, pregnancy-specific beta-1-glycoprotein 2 overexpression suppressed proliferation, migration, invasion, and epithelial–mesenchymal transition, downregulated MMP2 and MMP9 expression, and induced S-phase cell cycle arrest and late apoptosis. Conversely, pregnancy-specific beta-1-glycoprotein 2 knockdown exerted opposing effects without influencing cell cycle distribution or apoptosis. Immunofluorescence staining verified the co-localization of pregnancy-specific beta-1-glycoprotein 2 and TGF-β1 in trophoblasts and placental tissues. Mechanistically, pregnancy-specific beta-1-glycoprotein 2 activated the TGF-β/Smad3 signaling pathway, and the TGFBR1 inhibitor SB431542 effectively reversed pregnancy-specific beta-1-glycoprotein 2-mediated inhibition of epithelial–mesenchymal transition, MMP2/MMP9 expression, and trophoblast functional impairment. In conclusion, highly expressed pregnancy-specific beta-1-glycoprotein 2 in preeclampsia placentas contributes to preeclampsia pathogenesis by activating the TGF-β/Smad3 pathway, thereby inhibiting epithelial–mesenchymal transition and matrix metalloproteinases expression and attenuating trophoblast proliferation, migration, and invasion. These findings provide a novel molecular basis for understanding preeclampsia pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Obstetrics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
ORCID-Profile: Yanping Qin, Sumei Wang
Zitieren
APA
Qin, Y., Meng, S., Chen, S., Lv, C., Wang, C., Su, J., Lin, C., Xu, Y., Lin, M., & Wang, S. (2026). PSG2 impairs human trophoblast function in preeclampsia by activating TGF-β/Smad3 to suppress EMT and MMP2/9 expression. Biology of Reproduction. https://doi.org/10.1093/biolre/ioag168
Vancouver
Qin Y, Meng S, Chen S, Lv C, Wang C, Su J, et al. PSG2 impairs human trophoblast function in preeclampsia by activating TGF-β/Smad3 to suppress EMT and MMP2/9 expression. Biology of Reproduction. 2026. doi:10.1093/biolre/ioag168
BibTeX
@article{Qin2026,
author = {Qin, Yanping and Meng, Shengping and Chen, Siying and Lv, Chunyan and Wang, Chenguang and Su, Junyou and Lin, Chuzhen and Xu, Yajuan and Lin, Mengru and Wang, Sumei},
title = {PSG2 impairs human trophoblast function in preeclampsia by activating TGF-β/Smad3 to suppress EMT and MMP2/9 expression},
journal = {Biology of Reproduction},
year = {2026},
doi = {10.1093/biolre/ioag168}
}
EUVIMED